5-HT7 receptor signaling: Improved therapeutic strategy in GUT disorders

Frontiers in Behavioral Neuroscience

Volumn 8, Issue DEC, 2014, Pages

  Kim, Janice J ^a   Khan, Waliul I ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

Inflammatory bowel disease; Serotonin receptor type 7

Indexed keywords

3 [2 [2 (4 METHYL 1 PIPERIDINYL)ETHYL] 1 PYRROLIDINESULFONYL]PHENOL; 3,N DIMETHYL N [1 METHYL 3 (4 METHYL 1 PIPERIDINYL)PROPYL]BENZENESULFONAMIDE; SEROTONIN 7 RECEPTOR; TELOTRISTAT ETIPRATE;

CENTRAL NERVOUS SYSTEM; COLITIS; DIGESTIVE SYSTEM; DISEASE ASSOCIATION; ENTEROPATHY; GASTROINTESTINAL TRACT; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION; GUT BRAIN AXIS; HUMAN; IMMUNOCOMPETENT CELL; INFLAMMATORY BOWEL DISEASE; INTESTINE INFECTION; IRRITABLE COLON; NONHUMAN; PATHOGENESIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS INHIBITION; PROTEIN TARGETING; REVIEW; SIGNAL TRANSDUCTION;

EID: 84917739149     PISSN: 16625153     EISSN: None     Source Type: Journal    
DOI: 10.3389/fnbeh.2014.00396     Document Type: Review

References (112)

1. Ahonen, A., Kyösola, K., and Penttilä, O. (1976). Enterochromaffin cells in macrophages in ulcerative colitis and irritable colon. Ann. Clin. Res. 8, 1-7.
2. Andresen, V., and Camilleri, M. (2006). Irritable bowel syndrome: recent and novel therapeutic approaches. Drugs66, 1073-1088. doi: 10.2165/00003495-200666080-00004
3. Arnett, H. A., and Viney, J. L. (2010). Gatekeepers of intestinal inflammation. Inflamm. Res. 59, 1-14. doi: 10.1007/s00011-009-0091-x
4. Bard, J. A., Zgombick, J., Adham, N., Vaysse, P., Branchek, T. A., and Weinshank, R. L. (1993). Cloning of a novel human serotonin receptor (5-HT7) positively linked to adenylate cyclase. J. Biol. Chem. 268, 23422-23426.
5. Bearcroft, C. P., Perrett, D., and Farthing, M. J. (1996). 5-hydroxytryptamine release into human jejunum by cholera toxin. Gut 39, 528-531. doi: 10.1136/gut.39.4.528
6. Beattie, D. T., and Smith, J. A. (2008). Serotonin pharmacology in the gastrointestinal tract: a review. Naunyn Schmiedebergs. Arch. Pharmacol. 377, 181-203. doi: 10.1007/s00210-008-0276-9
7. Belai, A., Boulos, P. B., Robson, T., and Burnstock, G. (1997). Neurochemical coding in the small intestine of patients with Crohn's disease. Gut 40, 767-774. doi: 10.1136/gut.40.6.767
8. Bercik, P., Park, A. J., Sinclair, D., Khoshdel, A., Lu, J., Huang, X., et al. (2011). The anxiolytic effect of Bifidobacterium longum NCC3001 involves vagal pathways for gut-brain communication. Neurogastroenterol. Motil. 23, 1132-1139. doi: 10.1111/j.1365-2982.2011.01796.x
9. Bercik, P., Verdu, E. F., Foster, J. A., Macri, J., Potter, M., Huang, X., et al. (2010). Chronic gastrointestinal inflammation induces anxiety-like behavior and alters central nervous system biochemistry in mice.Gastroenterology 139, 2102-2112.e1. doi: 10.1053/j.gastro.2010.06.063
10. Berndt, B. E., Zhang, M., Chen, G. H., Huffnagle, G. B., and Kao, J. Y. (2007). The role of dendritic cells in the development of acute dextran sulfate sodium colitis. J. Immunol. 179, 6255-6262. doi: 10.4049/jimmunol.179.9.6255
11. Bernstein, C. N., and Shanahan, F. (2008). Disorders of a modern lifestyle: reconciling the epidemiology of inflammatory bowel diseases. Gut 57, 1185-1191. doi: 10.1136/gut.2007.122143
12. Bertrand, P. P., and Bertrand, R. L. (2010). Serotonin release and uptake in the gastrointestinal tract. Auton. Neurosci. 153, 47-57. doi: 10.1016/j.autneu.2009.08.002
13. Bhalla, P., Saxena, P. R., and Sharma, H. S. (2002). Molecular cloning and tissue distribution of mRNA encoding porcine 5-HT7 receptor and its comparison with the structure of other species. Mol. Cell. Biochem. 238, 81-88. doi: 10.1023/A:1019959121602
14. Bischoff, S. C., Mailer, R., Pabst, O., Weier, G., Sedlik, W., Li, Z., et al. (2009). Role of serotonin in intestinal inflammation: knockout of serotonin reuptake transporter exacerbates 2,4,6-trinitrobenzene sulfonic acid colitis in mice. Am. J. Physiol. Gastrointest. Liver Physiol. 296, G685-G695. doi: 10.1152/ajpgi.90685.2008
15. Bishop, A. E., Pietroletti, R., Taat, C. W., Brummelkamp, W. H., and Polak, J. M. (1987). Increased populations of endocrine cells in Crohn's ileitis. Virchows Arch. A Pathol. Anat. Histopathol. 410, 391-396. doi: 10.1007/bf00712758
16. Bonaz, B. L., and Bernstein, C. N. (2013). Brain-gut interactions in inflammatory bowel disease. Gastroenterology144, 36-49. doi: 10.1053/j.gastro.2012.10.003
17. Bouma, G., and Strober, W. (2003). The immunological and genetic basis of inflammatory bowel disease. Nat. Rev. Immunol. 3, 521-533. doi: 10.1038/nri1132
18. Carter, D., Champney, M., Hwang, B., and Eglen, R. M. (1995). Characterization of a postjunctional 5-HT receptor mediating relaxation of guinea-pig isolated ileum. Eur. J. Pharmacol. 280, 243-250. doi: 10.1016/0014-2999(95)00195-q
19. Chan, A. K., and von der Weid, P.-Y. (2003). 5-HT decreases contractile and electrical activities in lymphatic vessels of the guinea-pig mesentery: role of 5-HT 7-receptors. Br. J. Pharmacol. 139, 243-254. doi: 10.1038/sj.bjp.0705264
20. Chen, J. J., Li, Z., Pan, H., Murphy, D. L., Tamir, H., Koepsell, H., et al. (2001). Maintenance of serotonin in the intestinal mucosa and ganglia of mice that lack the high-affinity serotonin transporter: abnormal intestinal motility and the expression of cation transporters. J. Neurosci. 21, 6348-6361.
21. Coates, M. D., Mahoney, C. R., Linden, D. R., Sampson, J. E., Chen, J., Blaszyk, H., et al. (2004). Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome. Gastroenterology 126, 1657-1664. doi: 10.1053/j.gastro.2004.03.013
22. Cole, J. A., Cook, S. F., Sands, B. E., Ajene, A. N., Miller, D. P., and Walker, A. M. (2004). Occurrence of colon ischemia in relation to irritable bowel syndrome. Am. J. Gastroenterol. 99, 486-491. doi: 10.1111/j.1572-0241.2004.04097.x
23. Collins, S. M., and Bercik, P. (2009). The relationship between intestinal microbiota and the central nervous system in normal gastrointestinal function and disease. Gastroenterology 136, 2003-2014. doi: 10.1053/j.gastro.2009.01.075
24. Collins, S. M., Surette, M., and Bercik, P. (2012). The interplay between the intestinal microbiota and the brain. Nat. Rev. Microbiol. 10, 735-742. doi: 10.1038/nrmicro2876
25. Cryan, J. F., and O'Mahony, S. M. (2011). The microbiome-gut-brain axis: from bowel to behavior.Neurogastroenterol. Motil. 23, 187-192. doi: 10.1111/j.1365-2982.2010.01664.x
26. de las Casas-Engel, M., Domínguez-Soto, A., Sierra-Filardi, E., Bragado, R., Nieto, C., Puig-Kroger, A., et al. (2013). Serotonin skews human macrophage polarization through HTR2B and HTR7. J. Immunol. 190, 2301-2310. doi: 10.4049/jimmunol.1201133
27. Dickson, E. J., Heredia, D. J., and Smith, T. K. (2010). Critical role of 5-HT1A, 5-HT3 and 5-HT7 receptor subtypes in the initiation, generation and propagation of the murine colonic migrating motor complex. Am. J. Physiol. Gastrointest. Liver Physiol. 299, G144-G157. doi: 10.1152/ajpgi.00496.2009
28. El Aidy, S., Kunze, W., Bienenstock, J., and Kleerebezem, M. (2012). The microbiota and the gut-brain axis: insights from the temporal and spatial mucosal alterations during colonisation of the germfree mouse intestine. Benef. Microbes 3, 251-259. doi: 10.3920/BM2012.0042
29. El-Salhy, M., Danielsson, A., Stenling, R., and Grimelius, L. (1997). Colonic endocrine cells in inflammatory bowel disease. J. Intern. Med. 242, 413-419. doi: 10.1046/j.1365-2796.1997.00237.x
30. Fedorak, R. N., Wong, K., and Bridges, R. (2010). Canadian digestive health foundation public impact series. Inflammatory bowel disease in Canada: incidence, prevalence and direct and indirect economic impact. Can. J. Gastroenterol. 24, 651-655.
31. Forsythe, P., and Kunze, W. A. (2013). Voices from within: gut microbes and the CNS. Cell. Mol. Life Sci. 70, 55-69. doi: 10.1007/s00018-012-1028-z
32. Gershon, M. D., and Tack, J. (2007). The serotonin signaling system: from basic understanding to drug development for functional GI disorders. Gastroenterology 132, 397-414. doi: 10.1053/j.gastro.2006.11.002
33. Ghia, J. E., Li, N., Wang, H., Collins, M., Deng, Y., El-Sharkawy, R. T., et al. (2009). Serotonin has a key role in pathogenesis of experimental colitis. Gastroenterology 137, 1649-1660. doi: 10.1053/j.gastro.2009.08.041
34. Goodhand, J. R., Greig, F. I. S., Koodun, Y., McDermott, A., Wahed, M., Langmead, L., et al. (2012). Do antidepressants influence the disease course in inflammatory bowel disease? A retrospective case-matched observational study. Inflamm. Bowel Dis. 18, 1232-1239. doi: 10.1002/ibd.21846
35. Graff, L. A., Walker, J. R., and Bernstein, C. N. (2009). Depression and anxiety in inflammatory bowel disease: a review of comorbidity and management. Inflamm. Bowel Dis. 15, 1105-1118. doi: 10.1002/ibd.20873
36. Gunawardene, A. R., Corfe, B. M., and Staton, C. A. (2011). Classification and functions of enteroendocrine cells of the lower gastrointestinal tract. Int. J. Exp. Pathol. 92, 219-231. doi: 10.1111/j.1365-2613.2011.00767.x
37. Guseva, D., Holst, K., Kaune, B., Meier, M., Keubler, L., Glage, S., et al. (2014). Serotonin 5-HT7 receptor is critically involved in acute and chronic inflammation of the gastrointestinal tract. Inflamm. Bowel Dis. 20, 1516-1529. doi: 10.1097/MIB.0000000000000150
38. Ham, T. S. (2002). Regional distribution and relative frequency of gastrointestinal endocrine cells in large intestines of C57BL/6 mice. J. Vet. Sci. 3, 233-238.
39. Haub, S., Ritze, Y., Bergheim, I., Pabst, O., Gershon, M. D., and Bischoff, S. C. (2010). Enhancement of intestinal inflammation in mice lacking interleukin 10 by deletion of the serotonin reuptake transporter. Neurogastroenterol. Motil. 22, 826-834, e229. doi: 10.1111/j.1365-2982.2010.01479.x
40. Hedlund, P. B. (2009). The 5-HT7 receptor and disorders of the nervous system: an overview.Psychopharmacology (Berl) 206, 345-354. doi: 10.1007/s00213-009-1626-0
41. Hedlund, P. B., Danielson, P. E., Thomas, E. A., Slanina, K., Carson, M. J., and Sutcliffe, J. G. (2003). No hypothermic response to serotonin in 5-HT7 receptor knockout mice. Proc. Natl. Acad. Sci. U S A 100, 1375-1380. doi: 10.1073/pnas.0337340100
42. Hoyer, D., Hannon, J. P., and Martin, G. R. (2002). Molecular, pharmacological and functional diversity of 5-HT receptors. Pharmacol. Biochem. Behav. 71, 533-554. doi: 10.1016/s0091-3057(01)00746-8
43. Iceta, R., Mesonero, J. E., Aramayona, J. J., and Alcalde, A. I. (2009). Expression of 5-HT1A and 5-HT7 receptors in Caco-2 cells and their role in the regulation of serotonin transporter activity. J. Physiol. Pharmacol. 60, 157-164.
44. Idzko, M., Panther, E., Stratz, C., Müller, T., Bayer, H., Zissel, G., et al. (2004). The serotoninergic receptors of human dendritic cells: identification and coupling to cytokine release. J. Immunol. 172, 6011-6019. doi: 10.4049/jimmunol.172.10.6011
45. Irving, H. R., Tan, Y. Y., Tochon-Danguy, N., Liu, H., Chetty, N., Desmond, P. V., et al. (2007). Comparison of 5-HT4 and 5-HT7 receptor expression and function in the circular muscle of the human colon. Life Sci. 80, 1198-1205. doi: 10.1016/j.lfs.2006.12.025
46. Janssen, P., Prins, N. H., Meulemans, A. L., and Lefebvre, R. A. (2002). Pharmacological characterization of the 5-HT receptors mediating contraction and relaxation of canine isolated proximal stomach smooth muscle. Br. J. Pharmacol. 136, 321-329. doi: 10.1038/sj.bjp.0704716
47. Khan, W. I., Motomura, Y., Wang, H., El-Sharkawy, R. T., Verdu, E. F., Verma-Gandhu, M., et al. (2006). Critical role of MCP-1 in the pathogenesis of experimental colitis in the context of immune and enterochromaffin cells. Am. J. Physiol. Gastrointest. Liver Physiol. 291, G803-G811. doi: 10.1152/ajpgi.00069.2006
48. Kim, J. J., Bridle, B. W., Ghia, J.-E., Wang, H., Syed, S. N., Manocha, M. M., et al. (2013a). Targeted inhibition of serotonin type 7 (5-HT7) receptor function modulates immune responses and reduces the severity of intestinal inflammation. J. Immunol. 190, 4795-4804. doi: 10.4049/jimmunol.1201887
49. Kim, J. J., Wang, H., Terc, J. D., Sunjic, I., Zambrowicz, B., Yang, Q. M., et al. (2013b). Sa2017 blocking peripheral serotonin synthesis by telotristat etiprate reduces the severity of both chemical- and infection-induced intestinal inflammation. Gastroenterology 144, S-360. doi: 10.1016/S0016-5085(13)61326-8
50. Kim, J. J., Wang, H., Zaman, T., Hedlund, P. B., Ghia, J.-E., and Khan, W. I. (2012). Role of 5-HT7 in intestinal muscle function and host defense in an enteric parastic infection. Neurogastroenterol. Motil. 24, 43-190. doi: 10.1111/j.1365-2982.2012.01997.x
51. Koloski, N. A., Bret, L., and Radford-Smith, G. (2008). Hygiene hypothesis in inflammatory bowel disease: a critical review of the literature. World J. Gastroenterol. 14, 165-173. doi: 10.3748/wjg.14.165
52. Kordasti, S., Sjövall, H., Lundgren, O., and Svensson, L. (2004). Serotonin and vasoactive intestinal peptide antagonists attenuate rotavirus diarrhoea. Gut 53, 952-957. doi: 10.1136/gut.2003.033563
53. Krishnan, V., and Nestler, E. J. (2008). The molecular neurobiology of depression. Nature 455, 894-902. doi: 10.1038/nature07455
54. Ku, S. K., Lee, H. S., and Lee, J. H. (2006). The regional distribution and relative frequency of gastrointestinal endocrine cells in the nude mice, Balb/c-nu/nu: an immunohistochemical study. Anat. Histol. Embryol. 35, 104-110. doi: 10.1111/j.1439-0264.2005.00645.x
55. Ladabaum, U. (2003). Safety, efficacy and costs of pharmacotherapy for functional gastrointestinal disorders: the case of alosetron and its implications. Aliment. Pharmacol. Ther. 17, 1021-1030. doi: 10.1046/j.1365-2036.2003.01545.x
56. Larsson, K., Lööf, L., Rönnblom, A., and Nordin, K. (2008). Quality of life for patients with exacerbation in inflammatory bowel disease and how they cope with disease activity. J. Psychosom. Res. 64, 139-148. doi: 10.1016/j.jpsychores.2007.10.007
57. Levenstein, S. (2002). Psychosocial factors in peptic ulcer and inflammatory bowel disease. J. Consult. Clin. Psychol. 70, 739-750. doi: 10.1037//0022-006x.70.3.739
58. Li, N., Ghia, J. E., Wang, H., McClemens, J., Cote, F., Suehiro, Y., et al. (2011). Serotonin activates dendritic cell function in the context of gut inflammation. Am. J. Pathol. 178, 662-671. doi: 10.1016/j.ajpath.2010.10.028
59. Linden, D. R., Foley, K. F., McQuoid, C., Simpson, J., Sharkey, K. A., and Mawe, G. M. (2005). Serotonin transporter function and expression are reduced in mice with TNBS-induced colitis. Neurogastroenterol. Motil. 17, 565-574. doi: 10.1111/j.1365-2982.2005.00673.x
60. Lipscomb, M. F., and Masten, B. J. (2002). Dendritic cells: immune regulators in health and disease. Physiol. Rev.82, 97-130. doi: 10.1152/physrev.00023.2001
61. Loftus, E. V. Jr. (2004). Clinical epidemiology of inflammatory bowel disease: incidence, prevalence and environmental influences. Gastroenterology 126, 1504-1517. doi: 10.1053/j.gastro.2004.01.063
62. Lovenberg, T. W., Baron, B. M., de Lecea, L., Miller, J. D., Prosser, R. A., Rea, M. A., et al. (1993). A novel adenylyl cyclase-activating serotonin receptor (5-HT7) implicated in the regulation of mammalian circadian rhythms.Neuron 11, 449-458. doi: 10.1016/0896-6273(93)90149-l
63. Lyte, M., Varcoe, J. J., and Bailey, M. T. (1998). Anxiogenic effect of subclinical bacterial infection in mice in the absence of overt immune activation. Physiol. Behav. 65, 63-68. doi: 10.1016/s0031-9384(98)00145-0
64. Magro, F., Vieira-Coelho, M. A., Fraga, S., Serrão, M. P., Veloso, F. T., Ribeiro, T., et al. (2002). Impaired synthesis or cellular storage of norepinephrine, dopamine and 5-hydroxytryptamine in human inflammatory bowel disease.Dig. Dis. Sci. 47, 216-224. doi: 10.1023/A:1013256629600
65. Mardini, H. E., Kip, K. E., and Wilson, J. W. (2004). Crohn's disease: a two-year prospective study of the association between psychological distress and disease activity. Dig. Dis. Sci. 49, 492-497. doi: 10.1023/b:ddas.0000020509.23162.cc
66. Margolis, K. G., Stevanovic, K., Li, Z., Yang, Q. M., Oravecz, T., Zambrowicz, B., et al. (2013). Pharmacological reduction of mucosal but not neuronal serotonin opposes inflammation in mouse intestine. Gut 63, 928-937. doi: 10.1136/gutjnl-2013-304901
67. Martel, F., Monteiro, R., and Lemos, C. (2003). Uptake of serotonin at the apical and basolateral membranes of human intestinal epithelial (Caco-2) cells occurs through the neuronal serotonin transporter (SERT). J. Pharmacol. Exp. Ther. 306, 355-362. doi: 10.1124/jpet.103.049668
68. Mawe, G. M., and Hoffman, J. M. (2013). Serotonin signalling in the gut-functions, dysfunctions and therapeutic targets. Nat. Rev. Gastroenterol. Hepatol. 10, 473-486. doi: 10.1038/nrgastro.2013.105
69. Meuser, T., Pietruck, C., Gabriel, A., Xie, G.-X., Lim, K.-J., and Pierce Palmer, P. (2002). 5-HT7 receptors are involved in mediating 5-HT-induced activation of rat primary afferent neurons. Life Sci. 71, 2279-2289. doi: 10.1016/s0024-3205(02)02011-8
70. Meyerhof, W., Obermüller, F., Fehr, S., and Richter, D. (1993). A novel rat serotonin receptor: primary structure, pharmacology and expression pattern in distinct brain regions. DNA Cell Biol. 12, 401-409. doi: 10.1089/dna.1993.12.401
71. Mikocka-Walus, A. A., Turnbull, D. A., Moulding, N. T., Wilson, I. G., Andrews, J. M., and Holtmann, G. J. (2006). Antidepressants and inflammatory bowel disease: a systematic review. Clin. Pract. Epidemiol. Ment. Health 2:24. doi: 10.1186/1745-0179-2-24
72. Mittermaier, C., Dejaco, C., Waldhoer, T., Oefferlbauer-Ernst, A., Miehsler, W., Beier, M., et al. (2004). Impact of depressive mood on relapse in patients with inflammatory bowel disease: a prospective 18-month follow-up study.Psychosom. Med. 66, 79-84. doi: 10.1097/01.psy.0000106907.24881.f2
73. Mnie-Filali, O., Lambas-Señas, L., Scarna, H., and Haddjeri, N. (2009). Therapeutic potential of 5-HT7 receptors in mood disorders. Curr. Drug Targets 10, 1109-1117. doi: 10.2174/138945009789735129
74. Mössner, R., and Lesch, K.-P. (1998). Role of serotonin in the immune system and in neuroimmune interactions.Brain Behav. Immun. 12, 249-271. doi: 10.1006/brbi.1998.0532
75. Motomura, Y., Ghia, J. E., Wang, H., Akiho, H., El-Sharkawy, R. T., Collins, M., et al. (2008). Enterochromaffin cell and 5-hydroxytryptamine responses to the same infectious agent differ in Th1 and Th2 dominant environments.Gut 57, 475-481. doi: 10.1136/gut.2007.129296
76. Mowat, A. M., and Bain, C. C. (2011). Mucosal macrophages in intestinal homeostasis and inflammation. J. Innate Immun. 3, 550-564. doi: 10.1159/000329099
77. Müller, T., Dürk, T., Blumenthal, B., Grimm, M., Cicko, S., Panther, E., et al. (2009). 5-hydroxytryptamine modulates migration, cytokine and chemokine release and T-cell priming capacity of dendritic cells in vitro and in vivo. PLoS One 4:e6453. doi: 10.1371/journal.pone.0006453
78. Nilsson, O., Ahlman, H., Geffard, M., Dahlström, A., and Ericson, L. E. (1987). Bipolarity of duodenal enterochromaffin cells in the rat. Cell Tissue Res. 248, 49-54. doi: 10.1007/bf01239961
79. O'Hara, J. R., Skinn, A. C., MacNaughton, W. K., Sherman, P. M., and Sharkey, K. A. (2006). Consequences of Citrobacter rodentium infection on enteroendocrine cells and the enteric nervous system in the mouse colon. Cell. Microbiol. 8, 646-660. doi: 10.1111/j.1462-5822.2005.00657.x
80. O'Mahony, S. M., Clarke, G., Borre, Y. E., Dinan, T. G., and Cryan, J. F. (2014). Serotonin, tryptophan metabolism and the brain-gut- microbiome axis. Behav. Brain Res. doi: 10.1016/j.bbr.2014.07.027. [Epub ahead of print]
81. Oshima, S., Fujimura, M., and Fukimiya, M. (1999). Changes in number of serotonin-containing cells and serotonin levels in the intestinal mucosa of rats with colitis induced by dextran sodium sulfate. Histochem. Cell Biol. 112, 257-263. doi: 10.1007/s004180050445
82. Persoons, P., Vermeire, S., Demyttenaere, K., Fischler, B., Vandenberghe, J., Van Oudenhove, L., et al. (2005). The impact of major depressive disorder on the short- and long-term outcome of Crohn's disease treatment with infliximab. Aliment. Pharmacol. Ther. 22, 101-110. doi: 10.1111/j.1365-2036.2005.02535.x
83. Plassat, J. L., Amlaiky, N., and Hen, R. (1993). Molecular cloning of a mammalian serotonin receptor that activates adenylate cyclase. Mol. Pharmacol. 44, 229-236.
84. Porcelli, P., Leoci, C., and Guerra, V. (1996). A prospective study of the relationship between disease activity and psychologic distress in patients with inflammatory bowel disease. Scand. J. Gastroenterol. 31, 792-796. doi: 10.3109/00365529609010354
85. Prins, N. H., Briejer, M. R., Van Bergen, P. J., Akkermans, L. M., and Schuurkes, J. A. (1999). Evidence for 5-HT7 receptors mediating relaxation of human colonic circular smooth muscle. Br. J. Pharmacol. 128, 849-852. doi: 10.1038/sj.bjp.0702762
86. Racké, K., Reimann, A., Schwörer, H., and Kilbinger, H. (1996). Regulation of 5-HT release from enterochromaffin cells. Behav. Brain Res. 73, 83-87. doi: 10.1016/0166-4328(96)00075-7
87. Rehfeld, J. F. (1998). The new biology of gastrointestinal hormones. Physiol. Rev. 78, 1087-1108.
88. Rindi, G., Leiter, A. B., Kopin, A. S., Bordi, C., and Solcia, E. (2004). The "normal" endocrine cell of the gut: changing concepts and new evidences. Ann. N Y Acad. Sci. 1014, 1-12. doi: 10.1196/annals.1294.001
89. Roberts, A. J., and Hedlund, P. B. (2012). The 5-HT(7) receptor in learning and memory. Hippocampus 22, 762-771. doi: 10.1002/hipo.20938
90. Ruat, M., Traiffort, E., Leurs, R., Tardivel-Lacombe, J., Diaz, J., Arrang, J. M., et al. (1993). Molecular cloning, characterization and localization of a high-affinity serotonin receptor (5-HT7) activating cAMP formation. Proc. Natl. Acad. Sci. U S A 90, 8547-8551. doi: 10.1073/pnas.90.18.8547
91. Ruhé, H. G., Mason, N. S., and Schene, A. H. (2007). Mood is indirectly related to serotonin, norepinephrine and dopamine levels in humans: a meta-analysis of monoamine depletion studies. Mol. Psychiatry 12, 331-359. doi: 10.1038/sj.mp.4001949
92. Savelieva, K. V., Zhao, S., Pogorelov, V. M., Rajan, I., Yang, Q., Cullinan, E., et al. (2008). Genetic disruption of both tryptophan hydroxylase genes dramatically reduces serotonin and affects behavior in models sensitive to antidepressants. PLoS One 3:e3301. doi: 10.1371/journal.pone.0003301
93. Schäfermeyer, A., Gratzl, M., Rad, R., Dossumbekova, A., Sachs, G., and Prinz, C. (2004). Isolation and receptor profiling of ileal enterochromaffin cells. Acta Physiol. Scand. 182, 53-62. doi: 10.1111/j.1365-201x.2004.01299.x
94. Shajib, M. S., Wang, H., Kim, J. J., Sunjic, I., Ghia, J.-E., Denou, E., et al. (2013). Interleukin 13 and serotonin: linking the immune and endocrine systems in murine models of intestinal inflammation. PLoS One 8:e72774. doi: 10.1371/journal.pone.0072774
95. Sharkey, K. A., and Mawe, G. M. (2002). Neuroimmune and epithelial interactions in intestinal inflammation. Curr. Opin. Pharmacol. 2, 669-677. doi: 10.1016/s1471-4892(02)00215-1
96. Shen, Y., Monsma, F. J., Metcalf, M. A., Jose, P. A., Hamblin, M. W., Sibley, D. R., et al. (1993). Molecular cloning and expression of a 5-hydroxytryptamine7 serotonin receptor subtype. J. Biol. Chem. 268, 18200-18204.
97. Spiller, R. C., Jenkins, D., Thornley, J. P., Hebden, J. M., Wright, T., Skinner, M., et al. (2000). Increased rectal mucosal enteroendocrine cells, T lymphocytes and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut 47, 804-811. doi: 10.1136/gut.47.6.804
98. Tonini, M., Vicini, R., Cervio, E., De Ponti, F., De Giorgio, R., Barbara, G., et al. (2005). 5-HT7 receptors modulate peristalsis and accommodation in the guinea pig ileum. Gastroenterology 129, 1557-1566. doi: 10.1053/j.gastro.2005.08.005
99. Trivedi, M. H., Rush, A. J., Wisniewski, S. R., Nierenberg, A. A., Warden, D., Ritz, L., et al. (2006). Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am. J. Psychiatry 163, 28-40. doi: 10.1176/appi.ajp.163.1.28
100. Tsou, A. P., Kosaka, A., Bach, C., Zuppan, P., Yee, C., Tom, L., et al. (1994). Cloning and expression of a 5-hydroxytryptamine7 receptor positively coupled to adenylyl cyclase. J. Neurochem. 63, 456-464. doi: 10.1046/j.1471-4159.1994.63020456.x
101. Tuladhar, B. R., Ge, L., and Naylor, R. J. (2003). 5-HT7 receptors mediate the inhibitory effect of 5-HT on peristalsis in the isolated guinea-pig ileum. Br. J. Pharmacol. 138, 1210-1214. doi: 10.1038/sj.bjp.0705184
102. Turvill, J. L., Connor, P., and Farthing, M. J. (2000). The inhibition of cholera toxin-induced 5-HT release by the 5-HT(3) receptor antagonist, granisetron, in the rat. Br. J. Pharmacol. 130, 1031-1036. doi: 10.1038/sj.bjp.0703414
103. Vanhoenacker, P., Haegeman, G., and Leysen, J. E. (2000). 5-HT7 receptors: current knowledge and future prospects. Trends Pharmacol. Sci. 21, 70-77. doi: 10.1016/s0165-6147(99)01432-7
104. Walker, J. R., Ediger, J. P., Graff, L. A., Greenfeld, J. M., Clara, I., Lix, L., et al. (2008). The Manitoba IBD cohort study: a population-based study of the prevalence of lifetime and 12-month anxiety and mood disorders. Am. J. Gastroenterol. 103, 1989-1997. doi: 10.1111/j.1572-0241.2008.01980.x
105. Walker, E. A., Gelfand, M. D., Gelfand, A. N., Creed, F., and Katon, W. J. (1996). The relationship of current psychiatric disorder to functional disability and distress in patients with inflammatory bowel disease. Gen. Hosp. Psychiatry 18, 220-229. doi: 10.1016/0163-8343(96)00036-9
106. Walther, D. J., and Bader, M. (2003). A unique central tryptophan hydroxylase isoform. Biochem. Pharmacol. 66, 1673-1680. doi: 10.1016/s0006-2952(03)00556-2
107. Walther, D. J., Peter, J. U., Bashammakh, S., Hörtnagl, H., Voits, M., Fink, H., et al. (2003). Synthesis of serotonin by a second tryptophan hydroxylase isoform. Science 299:76. doi: 10.1126/science.1078197
108. Wang, H., Steeds, J., Motomura, Y., Deng, Y., Verma-Gandhu, M., El-Sharkawy, R. T., et al. (2007). CD4+ T cell-mediated immunological control of enterochromaffin cell hyperplasia and 5-hydroxytryptamine production in enteric infection. Gut 56, 949-957. doi: 10.1136/gut.2006.103226
109. Wheatcroft, J., Wakelin, D., Smith, A., Mahoney, C. R., Mawe, G., and Spiller, R. (2005). Enterochromaffin cell hyperplasia and decreased serotonin transporter in a mouse model of postinfectious bowel dysfunction.Neurogastroenterol. Motil. 17, 863-870. doi: 10.1111/j.1365-2982.2005.00719.x
110. Whitehead, W. E., Palsson, O., and Jones, K. R. (2002). Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications? Gastroenterology 122, 1140-1156. doi: 10.1053/gast.2002.32392
111. Yang, G. B., and Lackner, A. A. (2004). Proximity between 5-HT secreting enteroendocrine cells and lymphocytes in the gut mucosa of rhesus macaques (Macaca mulatta) is suggestive of a role for enterochromaffin cell 5-HT in mucosal immunity. J. Neuroimmunol. 146, 46-49. doi: 10.1016/j.jneuroim.2003.10.044
112. Zou, B. C., Dong, L., Wang, Y., Wang, S. H., and Cao, M. B. (2007). Expression and role of 5-HT7 receptor in brain and intestine in rats with irritable bowel syndrome. Chin. Med. J. (Engl) 120, 2069-2074.